#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleural mesothelioma Polycythaemia vera Microscopic polyangiitis B-cell lymphoma refractory Malignant glioma Adrenogenital syndrome Obliterative bronchiolitis Skin angiosarcoma Chronic inflammatory demyelinating polyradiculoneuropathy Dermatitis Cytomegalovirus infection Fallopian tube cancer Arrhythmogenic right ventricular dysplasia Medulloblastoma Laryngeal squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Synovial sarcoma metastatic – Treatment Chondrosarcoma metastatic – Life with Disease Phenylketonuria Angiosarcoma metastatic – Life with Disease Haemophilia B with anti factor IX Toxic epidermal necrolysis – Treatment Leiomyosarcoma – Trials in Disease Hepatoblastoma – Trials in Disease Ewing’s sarcoma metastatic – Basic Information Anaplastic thyroid cancer – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ep0031 Sitagliptin Mometasone Furoate Ph. Eur. Sodium Iodide (131I) Pentetic Acid Albiglutide Agrostis Stolonifera Pollen Cevostamab Sar441566 Elezanumab O15-Water CITRIC ACID ANHYDROUS Evx-01 KETOROLAC Tulisokibart LTG-001 ABIRATERONE DECANOATE Artemisia Vulgaris Ecoo75 M-(18F)-Fluorobenzylguanidine More therapies…

    Learn about Your Condition

    Lichen planus Cardiac arrest Leukoencephalopathy Mumps Glucose tolerance impaired Fracture infection Neuroblastoma Acute myeloid leukaemia Retinopathy proliferative Osteomyelitis acute CDKL5 deficiency disorder Becker's muscular dystrophy Cerebral haemorrhage Labour induction Colorectal cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Luxembourg

  • Study on Long-term Safety of NVDX3 Implant for Patients with Distal Radius Fracture or Low-grade Degenerative Lumbar Spondylolisthesis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Radius fracture
    Investigated Drugs:
    • Nvdx3
    Luxembourg

  • Study Comparing Short-Course Radiotherapy and Drug Combination for Older Patients with Locally Advanced Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Metoclopramide
    • Ondansetron
    • Capecitabine
    Belgium

  • Efficacy of intravenous prasinezumab versus placebo in Parkinson’s disease patients with severe GBA mutation: a 104‑week randomized double‑blind study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    • Sodium Chloride
    France Germany Italy Luxembourg Spain Sweden

  • A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    Belgium Bulgaria Czechia France Germany Poland +2

  • Study on the Effectiveness of Paclitaxel, Carboplatin, and Durvalumab for Patients with Extensive Stage Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Carboplatin
    • Durvalumab
    • Paclitaxel
    France Luxembourg

  • Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson’s Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    Austria France Italy Luxembourg Poland Spain
Previous Page
1 2 3 4 … 6
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Fluorouracil Paclitaxel Capecitabine Oxaliplatin Folinic Acid Docetaxel Carboplatin Acetylsalicylic Acid Nivolumab Bevacizumab Prednisone Datopotamab Deruxtecan Olaparib Dexamethasone Prasinezumab Paclitaxel Albumin-Bound Sodium Chloride Pembrolizumab Prednisolone Acetate Fulvestrant Durvalumab Placebo Gemcitabine Hydrochloride Mps-103 Baricitinib Mycophenolate Mofetil Ribociclib Regn7508 Bemarituzumab Mps-106 Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute coronary syndrome Adenocarcinoma gastric Bladder transitional cell carcinoma Breast cancer Breast cancer metastatic Breast cancer stage IV Cervix carcinoma recurrent Chronic coronary syndrome Colon cancer stage II Colon cancer stage III Colorectal cancer metastatic Ductal adenocarcinoma of pancreas Embolism Endometrial cancer Endometrial cancer recurrent Fallopian tube cancer Gastric cancer Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-refractory prostate cancer Lung disorder Malignant peritoneal neoplasm Neoplasm Non-small cell lung cancer Oesophageal adenocarcinoma Oesophageal carcinoma Ovarian cancer Ovarian cancer recurrent Ovarian epithelial cancer Parkinson's disease Prostate cancer Radius fracture Rectal cancer stage II Rectal cancer stage III Small cell lung cancer extensive stage

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!